                                                    Concept  PeriodEnd                                                                                                                                                                                                                                       Dims         Value
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.861000e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.693400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.698200e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.440000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.820000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  2.990000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                                                                             2.875400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                                                                             2.711600e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                                                                             2.728100e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.085500e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.509000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.060000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.342300e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  9.692000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.253000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  9.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.185000e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  8.510000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.103000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  7.770000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.039000e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.902000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.000000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.100000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  2.113000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.771000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.000000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.140000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.985000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.631000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.180000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.230000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.872000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.498000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.800000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  8.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.762000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.752000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  2.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.030000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  2.060000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.983000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  2.840000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.360000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  2.404000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  9.570000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  2.900000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  4.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  1.288000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  1.012000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  2.940000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  4.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  1.350000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  1.058000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  3.640000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  4.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  1.469000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                               srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  4.500000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                         srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.300000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                   srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  5.920000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                               srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  3.820000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                         srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                   srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  5.290000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                               srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  3.480000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                         srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.680000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                   srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  5.300000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  2.570000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  1.290000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  4.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  4.340000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  2.380000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  1.160000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  4.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  4.010000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  2.900000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  1.820000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  5.900000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  5.300000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.591800e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  2.339000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.355000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.961200e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.484800e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  2.102000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.226000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.817500e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.382000e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  2.219000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.155000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.719400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                    srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  9.220000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                              srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  2.990000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                        srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  3.740000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  1.596000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                    srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  8.590000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                              srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  3.230000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                        srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  3.550000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  1.537000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                    srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  8.440000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                              srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  3.550000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                        srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  3.310000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  1.530000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                  srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  4.860000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                            srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  4.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                      srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  4.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  9.590000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                  srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  4.100000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                            srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  3.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                      srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  4.140000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  8.620000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                  srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  4.290000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                            srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  3.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                      srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  3.790000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  8.420000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  1.920000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  2.020000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  7.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  4.670000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  1.520000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  1.500000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  8.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  3.850000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  1.670000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  1.350000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  1.240000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  4.260000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                 srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  1.601000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                           srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  5.450000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                     srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  8.760000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember  3.021000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                 srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  1.421000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                           srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  5.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                     srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  8.520000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember  2.784000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                 srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  1.440000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                           srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  5.250000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                     srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:LiverDiseaseMember  8.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember  2.798000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                      srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:VekluryMember  8.920000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:VekluryMember  2.840000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                          srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:VekluryMember  6.230000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember  1.799000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                      srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:VekluryMember  9.720000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:VekluryMember  4.080000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                          srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:VekluryMember  8.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember  2.184000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                      srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:VekluryMember  1.575000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:VekluryMember  7.020000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                          srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:VekluryMember  1.628000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember  3.905000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                  srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  2.340000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                            srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  1.380000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                      srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  3.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  4.030000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                  srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  2.450000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                            srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  1.100000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                      srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  1.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  3.700000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                  srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  2.210000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                            srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  7.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                      srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  3.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  2.990000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  6.620000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  6.660000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  2.420000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  1.570000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  8.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  5.470000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  1.400000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  1.498000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  7.470000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  3.550000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  5.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  1.160000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  8.960000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  8.040000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  2.740000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  1.973000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  1.055000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  6.580000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  1.560000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  1.869000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  9.680000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  4.300000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  6.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  1.459000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                     srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:TrodelvyMember  9.020000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                               srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:TrodelvyMember  2.940000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                         srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:TrodelvyMember  1.190000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember  1.315000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                     srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:TrodelvyMember  7.770000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                               srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:TrodelvyMember  2.170000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                         srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:TrodelvyMember  6.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember  1.063000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                     srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:TrodelvyMember  5.250000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                               srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:TrodelvyMember  1.430000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                         srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:TrodelvyMember  1.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember  6.800000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OncologyProductMember  1.798000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OncologyProductMember  1.098000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OncologyProductMember  3.930000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember  3.289000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OncologyProductMember  1.833000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OncologyProductMember  8.750000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OncologyProductMember  2.240000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember  2.932000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                              srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OncologyProductMember  1.494000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                        srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OncologyProductMember  5.730000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                  srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OncologyProductMember  7.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember  2.139000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  4.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  2.760000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  2.120000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  5.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  4.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  2.600000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  1.890000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  4.920000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                        srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  5.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                  srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  2.580000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                            srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  1.820000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  4.970000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  2.550000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  3.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  6.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  3.560000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  2.610000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  4.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  6.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  3.670000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                           srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  3.310000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                     srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  6.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                               srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  5.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  4.490000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  2.990000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  3.100000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  2.800000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  8.890000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  3.040000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  3.010000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  2.550000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  8.590000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                          srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  3.880000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                    srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  3.230000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                              srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  2.350000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  9.460000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                   srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:us-gaap:ProductMember  2.050800e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:us-gaap:ProductMember  4.576000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:us-gaap:ProductMember  3.526000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.861000e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                   srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:us-gaap:ProductMember  1.937700e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:us-gaap:ProductMember  4.197000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:us-gaap:ProductMember  3.361000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.693400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                   srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:us-gaap:ProductMember  1.871600e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:us-gaap:ProductMember  4.342000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:us-gaap:ProductMember  3.924000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.698200e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                      srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  8.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  5.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                          srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  4.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.440000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                      srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  6.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.140000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                          srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  7.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.820000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                      srt:StatementGeographicalAxis:country:US; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.680000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                srt:StatementGeographicalAxis:srt:EuropeMember; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.270000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                          srt:StatementGeographicalAxis:gild:RestOfWorldMember; srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  4.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  2.990000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                                   srt:StatementGeographicalAxis:country:US  2.059100e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember  4.634000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.529000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31                                                                                                                                                                                                                                             2.875400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                                   srt:StatementGeographicalAxis:country:US  1.943800e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember  4.310000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.368000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2023-12-31                                                                                                                                                                                                                                             2.711600e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                                   srt:StatementGeographicalAxis:country:US  1.888400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember  4.469000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.928000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31                                                                                                                                                                                                                                             2.728100e+10
                                us-gaap:OperatingIncomeLoss 2024-12-31                                                                                                                                                                                                                                             1.662000e+09
                                us-gaap:OperatingIncomeLoss 2023-12-31                                                                                                                                                                                                                                             7.605000e+09
                                us-gaap:OperatingIncomeLoss 2022-12-31                                                                                                                                                                                                                                             7.330000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  7.345000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  7.515000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.101300e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.107400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  4.240000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  3.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  5.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                                                             7.769000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                                                             7.545000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                                                             2.151800e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                                                             2.118500e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:country:US  2.940000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.270000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.200000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  3.686000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:country:US  2.826000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.750000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.720000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  3.472000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:country:US  6.520000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  7.010000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:country:US  5.340000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  5.860000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:country:US  3.230000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.900000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  3.770000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:country:US  3.840000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  4.490000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:country:US  2.060000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:srt:EuropeMember  6.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  2.770000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:country:US  2.480000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:srt:EuropeMember  6.900000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  3.260000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:country:US  9.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                   srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.240000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:country:US  1.030000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                   srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  1.390000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:country:US  8.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  1.120000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:country:US  6.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  1.000000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:country:US  4.299000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  5.920000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.860000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember  5.277000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:country:US  4.161000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  5.700000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.420000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember  5.073000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:country:US  1.460000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:srt:EuropeMember  6.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  3.090000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:country:US  2.220000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:srt:EuropeMember  6.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  3.850000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:country:US  1.360000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.320000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  2.800000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:country:US  1.260000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  2.320000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:country:US  1.320000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  2.310000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:country:US  4.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  5.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  1.160000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                 srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:country:US  4.140000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.580000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.470000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember  8.190000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                 srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:country:US  3.930000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.320000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.070000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember  7.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                      srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:country:US  1.400000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember  2.770000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                      srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:country:US  3.930000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.190000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember  6.920000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:country:US  4.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  8.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  8.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:country:US  6.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.900000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  6.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  9.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:country:US  1.230000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.510000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  7.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  3.490000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:country:US  1.450000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.820000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  6.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  3.870000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                              srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:country:US  1.630000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.860000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  8.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  4.320000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                              srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:country:US  2.080000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  6.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  4.850000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                     srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:country:US  2.210000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.900000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                         srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  4.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember  3.570000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                     srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:country:US  2.260000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                         srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember  3.320000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:country:US  3.840000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.750000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.290000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember  7.880000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:country:US  4.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.910000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember  8.160000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:country:US  2.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:srt:EuropeMember  6.900000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  1.230000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:country:US  6.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:srt:EuropeMember  7.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  1.300000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:country:US  3.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  7.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  6.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:country:US  4.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  7.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:country:US  3.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  7.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                              srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  7.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  1.840000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:country:US  5.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                              srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  6.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  2.010000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                   srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:country:US  5.274000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.144000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                       srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  7.345000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                   srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:country:US  5.433000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.154000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                       srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  7.515000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                      srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:country:US  7.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  4.240000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                      srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:country:US  1.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  3.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                   srt:StatementGeographicalAxis:country:US  5.281000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember  1.555000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                                                             7.769000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                   srt:StatementGeographicalAxis:country:US  5.450000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember  1.167000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.290000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                                                             7.545000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:country:US  8.212000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.231000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.220000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  1.036600e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:country:US  7.726000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.110000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  8.140000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsBiktarvyMember  9.649000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:country:US  1.791000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:srt:EuropeMember  6.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  8.100000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.939000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:country:US  1.339000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:srt:EuropeMember  7.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  8.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsDescovyMember  1.496000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:country:US  9.500000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.140000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.118000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:country:US  1.088000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.380000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  6.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsGenvoyaMember  1.292000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:country:US  6.420000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.840000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  8.570000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:country:US  7.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.170000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.000000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:HIVProductsOdefseyMember  9.520000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:country:US  2.650000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                   srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  3.620000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:country:US  3.380000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.010000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                   srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  9.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                         srt:ProductOrServiceAxis:gild:HIVProductsSymtuzaRevenueShareMember  4.480000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:country:US  1.980000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  3.100000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:country:US  1.900000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:srt:EuropeMember  9.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                    srt:ProductOrServiceAxis:gild:HIVProductsOtherHIVMember  3.220000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:country:US  1.205900e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.769000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.124000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.495200e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:country:US  1.138600e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.737000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:HIVProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.038000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:HIVProductSalesMember  1.416000e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:country:US  4.970000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.270000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.730000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  9.960000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:country:US  7.370000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.300000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.990000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                              srt:ProductOrServiceAxis:gild:LiverDiseaseProductsSofosbuvirVelpatasvirMember  1.266000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:country:US  3.580000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.890000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  7.830000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:country:US  3.380000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsVemlidyMember  6.990000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:country:US  3.070000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  5.930000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                        srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:country:US  1.340000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.480000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                            srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                  srt:ProductOrServiceAxis:gild:LiverDiseaseProductsOtherLiverDiseaseMember  3.370000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                 srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:country:US  1.162000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.960000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  7.140000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember  2.372000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                 srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:country:US  1.210000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:LiverDiseaseMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  6.820000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                           srt:ProductOrServiceAxis:gild:LiverDiseaseMember  2.302000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                      srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:country:US  3.900000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.250000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember  7.000000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                      srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:country:US  7.840000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.040000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                          srt:ProductOrServiceAxis:gild:VekluryMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  4.730000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                srt:ProductOrServiceAxis:gild:VekluryMember  1.461000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:country:US  1.220000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.070000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  2.540000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:country:US  1.810000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:srt:EuropeMember  1.020000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                      srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                            srt:ProductOrServiceAxis:gild:CellTherapyProductsTecartusMember  3.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:country:US  4.440000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.550000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  1.127000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:country:US  5.020000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:srt:EuropeMember  5.090000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.700000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsYescartaMember  1.181000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                              srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:country:US  5.660000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  5.620000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.530000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  1.381000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                              srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:country:US  6.830000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  6.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                  srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.920000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                        srt:ProductOrServiceAxis:gild:CellTherapyProductsTotalCellTherapyProductSalesMember  1.485000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                     srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:country:US  6.260000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.590000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                         srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember  1.013000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                     srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:country:US  6.550000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.170000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                         srt:ProductOrServiceAxis:gild:TrodelvyMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  8.800000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                               srt:ProductOrServiceAxis:gild:TrodelvyMember  9.600000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:country:US  1.192000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.210000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  3.810000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember  2.395000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                              srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:country:US  1.338000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  8.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OncologyProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.800000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                        srt:ProductOrServiceAxis:gild:OncologyProductMember  2.446000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:country:US  1.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.010000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.750000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  3.910000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                        srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:country:US  3.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.100000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                            srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.760000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                  srt:ProductOrServiceAxis:gild:OtherProductsAmBisomeMember  4.240000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:country:US  1.250000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  2.040000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                           srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:country:US  2.030000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                               srt:ProductOrServiceAxis:gild:OtherProductsOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  5.200000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                     srt:ProductOrServiceAxis:gild:OtherProductsOtherMember  2.810000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:country:US  1.400000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.250000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                              srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.300000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  5.940000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:country:US  2.410000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:srt:EuropeMember  2.360000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                              srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.280000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                    srt:ProductOrServiceAxis:gild:OtherProductsTotalOtherProductSalesMember  7.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                   srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:country:US  1.494300e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.395000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                       srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.674000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.101300e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                   srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:country:US  1.495800e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:srt:EuropeMember  3.416000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                       srt:ProductOrServiceAxis:us-gaap:ProductMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.700000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                             srt:ProductOrServiceAxis:us-gaap:ProductMember  2.107400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                      srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:country:US  5.700000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.330000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  1.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  5.050000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                      srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:country:US  6.600000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:srt:EuropeMember  4.300000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                          srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember; srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.000000e+06
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                srt:ProductOrServiceAxis:gild:RoyaltyContractAndOtherMember  1.110000e+08
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                   srt:StatementGeographicalAxis:country:US  1.500000e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember  3.828000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.690000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30                                                                                                                                                                                                                                             2.151800e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                   srt:StatementGeographicalAxis:country:US  1.502400e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                             srt:StatementGeographicalAxis:srt:EuropeMember  3.459000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                       srt:StatementGeographicalAxis:gild:RestOfWorldMember  2.703000e+09
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30                                                                                                                                                                                                                                             2.118500e+10
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis:us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember; us-gaap:StatementEquityComponentsAxis:us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember -1.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis:us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember; us-gaap:StatementEquityComponentsAxis:us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember  1.400000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2025-09-30 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis:us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember; us-gaap:StatementEquityComponentsAxis:us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember  2.500000e+07
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax 2024-09-30 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis:us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember; us-gaap:StatementEquityComponentsAxis:us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember  1.900000e+07
                                us-gaap:OperatingIncomeLoss 2025-09-30                                                                                                                                                                                                                                             3.327000e+09
                                us-gaap:OperatingIncomeLoss 2024-09-30                                                                                                                                                                                                                                             8.880000e+08
                                us-gaap:OperatingIncomeLoss 2025-09-30                                                                                                                                                                                                                                             8.038000e+09
                                us-gaap:OperatingIncomeLoss 2024-09-30                                                                                                                                                                                                                                            -7.900000e+08